KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Other Non-Current Liabilities (2016 - 2025)

Merck (MRK) has disclosed Other Non-Current Liabilities for 14 consecutive years, with $7.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 18.92% to $7.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $7.7 billion, a 18.92% increase, with the full-year FY2025 number at $7.7 billion, up 18.92% from a year prior.
  • Other Non-Current Liabilities was $7.7 billion for Q4 2025 at Merck, up from $6.7 billion in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $8.3 billion in Q4 2022 to a low of $208.0 million in Q3 2024.
  • A 5-year average of $2.1 billion and a median of $572.0 million in 2022 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: plummeted 95.75% in 2023, then surged 2844.69% in 2025.
  • Merck's Other Non-Current Liabilities stood at $777.0 million in 2021, then soared by 971.17% to $8.3 billion in 2022, then crashed by 95.75% to $354.0 million in 2023, then soared by 1726.27% to $6.5 billion in 2024, then rose by 18.92% to $7.7 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Other Non-Current Liabilities are $7.7 billion (Q4 2025), $6.7 billion (Q1 2025), and $6.5 billion (Q4 2024).